Clinical Trial Update: Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial of adaptive MRI-guided SBRT for unresectable primary or oligometastatic central thorax and abdominal malignancies, including liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Hepatocellular Carcinoma
• Thoracic Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Central Thorax Cancer, Liver Cancer | Phase 1 | Status: COMPLETED